- Home
- SYRA vs PLRZ Comparison
SYRA vs PLRZ Comparison
Compare SYRA & PLRZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRA
- PLRZ
- Stock Information
- Founded
- SYRA 2020
- PLRZ 2005
- Country
- SYRA United States
- PLRZ Israel
- Employees
- SYRA N/A
- PLRZ N/A
- Industry
- SYRA Other Specialty Stores
- PLRZ
- Sector
- SYRA Industrials
- PLRZ
- Exchange
- SYRA Nasdaq
- PLRZ NYSE
- Market Cap
- SYRA 3.5M
- PLRZ 3.4M
- IPO Year
- SYRA 2023
- PLRZ 2024
- Fundamental
- Price
- SYRA $0.39
- PLRZ $3.29
- Analyst Decision
- SYRA
- PLRZ
- Analyst Count
- SYRA 0
- PLRZ 0
- Target Price
- SYRA N/A
- PLRZ N/A
- AVG Volume (30 Days)
- SYRA 247.7K
- PLRZ 7.3M
- Earning Date
- SYRA 10-29-2024
- PLRZ 02-15-2025
- Dividend Yield
- SYRA N/A
- PLRZ N/A
- EPS Growth
- SYRA N/A
- PLRZ N/A
- EPS
- SYRA N/A
- PLRZ N/A
- Revenue
- SYRA $7,741,558.00
- PLRZ N/A
- Revenue This Year
- SYRA $47.74
- PLRZ N/A
- Revenue Next Year
- SYRA N/A
- PLRZ N/A
- P/E Ratio
- SYRA N/A
- PLRZ N/A
- Revenue Growth
- SYRA 35.47
- PLRZ N/A
- 52 Week Low
- SYRA $0.34
- PLRZ $0.77
- 52 Week High
- SYRA $8.37
- PLRZ $4.80
- Technical
- Relative Strength Index (RSI)
- SYRA 44.58
- PLRZ N/A
- Support Level
- SYRA $0.36
- PLRZ N/A
- Resistance Level
- SYRA $0.43
- PLRZ N/A
- Average True Range (ATR)
- SYRA 0.04
- PLRZ 0.00
- MACD
- SYRA -0.00
- PLRZ 0.00
- Stochastic Oscillator
- SYRA 21.12
- PLRZ 0.00
About SYRA Syra Health Corp.
Syra Health Corp is a healthcare services company promoting preventative health, holistic wellness, health education, and equitable healthcare for all patient demographics. The company leverages deep scientific and healthcare expertise to create strategic frameworks and develop patient-centric solutions for the betterment of patient lives and health outcome linked to developing a healthier population. It strives to offer comprehensive end-to-end solutions in health education services, population health management, behavioral and mental health, healthcare workforce and digital health.
About PLRZ POLYRIZON LTD
Polyrizon Ltd is a clinical development stage biotech company specializing in the development of nasal gels to provide preventative treatment to protect against a wide cross-section of viruses, including certain variants of COVID-19 that are also considered to cause more infections and spread faster than the original strain of the virus (the CDC expects that additional variants of the virus will continue to occur), influenza, allergens, and other toxins. Its technology platforms are Capture & Contain and Trap & Target.